Saudi Arabia to Increase Oil Output in July to Record Rate

An oil tanker is being loaded at Saudi Aramco's Ras Tanura oil refinery and oil terminal in Saudi Arabia May 21, 2018. REUTERS/Ahmed Jadallah/File Photo
An oil tanker is being loaded at Saudi Aramco's Ras Tanura oil refinery and oil terminal in Saudi Arabia May 21, 2018. REUTERS/Ahmed Jadallah/File Photo
TT

Saudi Arabia to Increase Oil Output in July to Record Rate

An oil tanker is being loaded at Saudi Aramco's Ras Tanura oil refinery and oil terminal in Saudi Arabia May 21, 2018. REUTERS/Ahmed Jadallah/File Photo
An oil tanker is being loaded at Saudi Aramco's Ras Tanura oil refinery and oil terminal in Saudi Arabia May 21, 2018. REUTERS/Ahmed Jadallah/File Photo

State oil company Saudi Aramco is aiming to boost production next month to about 10.8 million barrels a day, the people said, asking not be named discussing confidential information. That would surpass the previous high of 10.72 million barrels a day in November 2016.

OPEC and other producers, Russia in the lead, stroke a deal on Saturday to increase the output after being urged by consuming states, including US, to increase product. Saudi Arabia said that the agreement will result in an increase of around one million barrel per day, or 1 percent of the global crude supplies.

It seems clear that Riyadh has been preparing for raising the output in the beginning of this month, based on what has been stated by Saudi Arabian Energy Minister Khalid Al-Falih in Vienna on Saturday when he said that Aramco received instructions to get ready to raise output.

Despite the deal, the US seems unsatisfied with the raise in which United States Secretary of Energy Richard Perry notified journalists on Monday that he sees the reached deal by OPEC and oil producing states in the beginning of the week might not be sufficient to alleviate pressures on the global oil markets resulting from supplies obstacles.

Perry stated that this deal might be a bit less than what the market needs.

The lion's share of the oil production increases agreed to by the Organization of the Petroleum Exporting Countries (OPEC) and non-OPEC oil producers will come from Saudi Arabia and its exports likely will be biased toward light crude, Energy Aspects said in a note on Monday.

Saudi Arabia and Russia to compensate for any additional future supply declines elsewhere, adding up to another 400,000 bpd.

Saudi Arabia's production is expected to average about 10.5 million bpd in Q3, with some months possibly averaging close to record highs above 10.6 million bpd.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.